Conference
P1.14-33 Canagliflozin Inhibits Lung Cancer Survival and Enhances Its Response to Radiotherapy; Effective Blockade of mTOR Pathway, HIF1a, and Mitosis
Authors
Tsakiridis E; Biziotis O; Zacharidis P; Broadfield L; Mekhaeil B; Menjolian G; Farell T; Abdulkarim B; Muti P; Steinberg G
Volume
14
Pagination
pp. s566-s567
Publisher
Elsevier
Publication Date
October 1, 2019
DOI
10.1016/j.jtho.2019.08.1184
Conference proceedings
Journal of Thoracic Oncology
Issue
10
ISSN
1556-0864